tiprankstipranks
Advertisement
Advertisement

HK:6160 Stock Latest News

BeOne Medicines price target lowered to $411 from $412 at Truist
The FlyBeOne Medicines price target lowered to $411 from $412 at Truist
2d ago
ONC
BeOne Medicines Grants RSUs to 154 Employees Under 2016 Incentive Plan
PremiumCompany Announcements
BeOne Medicines Grants RSUs to 154 Employees Under 2016 Incentive Plan
2d ago
6160
Buy Rating on BeOne Medicines: Strong Brukinsa Positioning, Deep Oncology Pipeline, and Attractive Valuation Ahead of 2026 Milestones
PremiumRatings
Buy Rating on BeOne Medicines: Strong Brukinsa Positioning, Deep Oncology Pipeline, and Attractive Valuation Ahead of 2026 Milestones
14d ago
ONC
BeOne Medicines initiated with an Outperform at Wolfe Research
PremiumThe Fly
BeOne Medicines initiated with an Outperform at Wolfe Research
14d ago
ONC
BeOne Medicines Swings to Profit on 40% Revenue Surge in 2025
PremiumCompany Announcements
BeOne Medicines Swings to Profit on 40% Revenue Surge in 2025
16d ago
6160
BeOne Medicines treatment of hepatocellular carcinoma granted orphan designation
PremiumThe FlyBeOne Medicines treatment of hepatocellular carcinoma granted orphan designation
18d ago
ONC
BeOne Medicines downgraded to Hold from Buy at Jefferies
Premium
The Fly
BeOne Medicines downgraded to Hold from Buy at Jefferies
25d ago
ONC
BeOne Medicines Updates HKEX Waivers and Compliance Disclosures
Premium
Company Announcements
BeOne Medicines Updates HKEX Waivers and Compliance Disclosures
28d ago
6160
BeOne Medicines Updates on Employee Share Purchase Plan Uptake
PremiumCompany Announcements
BeOne Medicines Updates on Employee Share Purchase Plan Uptake
29d ago
6160
BeOne Medicines Aligns 2025 Results With Dual Hong Kong and U.S. Reporting Rules
PremiumCompany Announcements
BeOne Medicines Aligns 2025 Results With Dual Hong Kong and U.S. Reporting Rules
30d ago
6160
BeOne Medicines Opens New 2018 Employee Share Purchase Plan Offering Period
PremiumCompany Announcements
BeOne Medicines Opens New 2018 Employee Share Purchase Plan Offering Period
1M ago
6160
BeOne Medicines Grants New RSUs to 188 Employees Under Incentive Plan
PremiumCompany Announcements
BeOne Medicines Grants New RSUs to 188 Employees Under Incentive Plan
1M ago
6160
KURE vs. VHT: Comparing China and U.S. Healthcare ETFs
PremiumMarket NewsKURE vs. VHT: Comparing China and U.S. Healthcare ETFs
1M ago
JNJ
LLY
Zymeworks, Royalty Pharma enter $250M royalty-backed note financing
Premium
The Fly
Zymeworks, Royalty Pharma enter $250M royalty-backed note financing
1M ago
ONC
JAZZ
BeOne Medicines price target raised to $412 from $400 at Truist
Premium
The Fly
BeOne Medicines price target raised to $412 from $400 at Truist
1M ago
ONC
BeOne Medicines price target raised to $425 from $417 at RBC Capital
PremiumThe Fly
BeOne Medicines price target raised to $425 from $417 at RBC Capital
1M ago
ONC
BeOne Medicines Gains Clean Swiss Audit in Voluntary Disclosure
PremiumCompany Announcements
BeOne Medicines Gains Clean Swiss Audit in Voluntary Disclosure
1M ago
6160
BeOne Medicines price target raised to $410 from $400 at Guggenheim
PremiumThe Fly
BeOne Medicines price target raised to $410 from $400 at Guggenheim
1M ago
ONC
BeOne Medicines price target raised to $405 from $394 at Barclays
PremiumThe Fly
BeOne Medicines price target raised to $405 from $394 at Barclays
1M ago
ONC
BeOne Medicines Files 2025 Form 10-K, Underscoring Cross-Border Compliance
PremiumCompany AnnouncementsBeOne Medicines Files 2025 Form 10-K, Underscoring Cross-Border Compliance
1M ago
6160
BeOne Medicines posts 2025 results and issues cautious 2026 outlook
Premium
Company Announcements
BeOne Medicines posts 2025 results and issues cautious 2026 outlook
1M ago
6160
BeOne Medicines reports Q4 adjusted EPS $1.95, consensus $1.30
Premium
The Fly
BeOne Medicines reports Q4 adjusted EPS $1.95, consensus $1.30
1M ago
ONC

Trending

Name
Price
Price Change
SPX
S&P 500
―
DJIA
Dow Jones
―
NDX
Nasdaq 100
―
More Trending Stocks >